FLT3-ITD mutations and TET2 loss synergistically alter global DNA methylation in AML
收藏官方服务：
资源简介：
FLT3-ITD mutations and TET2 loss synergistically alter global DNA methylation in AML
应用场景：
创建时间：
2015-04-14
相关数据集
Table 5_Local Promoter Methylation Disorder algorithm reveals bidirectional epigenetic disruption in DNMT3A-mutated AML and predicts azacitidine treatment response.xlsx
BackgroundDNMT3A mutations occur in 20-25% of acute myeloid leukemia (AML) cases and are associated with poor prognosis, yet the epigenetic mechanisms underlying treatment response remain poorly under
NIAID Data Ecosystem80
Supplementary Table 7 from Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia
GO Analysis from Regions of Differential MOLM13 H3K27Ac CUT&Tag (6 Hours After Drug Treatment) Pileup at Enhancers and Promoters
NIAID Data Ecosystem50
A molecular switch between mammalian MLL complexes dictates response to Menin-MLL inhibition [RNA-seq]. A molecular switch between mammalian MLL complexes dictates response to Menin-MLL inhibition [RNA-seq]
The chromatin adaptor Menin interacts with oncogenic fusion proteins encoded by MLL1-rearrangements (MLL1-r), and small molecules that disrupt these associations are currently in clinical trials for t
NIAID Data Ecosystem40
Inhibitors of LSD1 target demethylase-independent activity to induce differentiation in acute myeloid leukemia [anti-H3K9 ac, anti-H3K27, RCOR1, SPI1, and MLL4 ChIP-Seq]. Inhibitors of LSD1 target demethylase-independent activity to induce differentiation in acute myeloid leukemia [anti-H3K9 ac, anti-H3K27, RCOR1, SPI1, and MLL4 ChIP-Seq]
To determine whether changes in histone modifications directly correlate with changes in transcription, THP1 AML cells were treated with a potent and selective LSD1 inhibitor (OG86, 250nM) and then su
NIAID Data Ecosystem60
Mechanistic insights into chromatin targeting by leukemic NUP98-PHF23 fusion
The dysregulation of plant homeodomain (PHD) fingers has been implicated in several human diseases, including cancer. In a subset of aggressive acute myeloid leukemia (AML), chromosomal translocations
NIAID Data Ecosystem50
